Windtree
-
Analysis
Windtree Therapeutics Targets New $520 Million Fund To Boost Holdings
Windtree Therapeutics (WINT), a biotech agency listed on Nasdaq, has lately made headlines by venturing into the cryptocurrency area, significantly…
Read More »